SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tennyson Alfred Lord. Ulysses. In: Poems, in Two Volumes. London: Moxon; 1842.
  • 2
    Khuri FR, Lotan R, Kemp BL, et al. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol. 2000; 18: 2798-2804.
  • 3
    Liu NS, Spitz MR, Kemp BL, et al. Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer. 2000; 88: 1837-1841.
  • 4
    Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004; 350: 2129-2139.
  • 5
    Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004; 304: 1497-1500.
  • 6
    Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009; 27: 4247-4253.
  • 7
    Camidge DR, Theodoro M, Maxson DA, et al. Correlations between the percentage of tumor cells showing an ALK gene rearrangement, ALK signal copy number and response to crizotinib therapy in ALK FISH positive non-small cell lung cancer. Cancer. In press.
  • 8
    Friedman T. The World is Flat: A Brief History of the Twenty-First Century. 1st ed. New York: Farrar, Straus and Giroux; 2005.